Dexmedetomidine attenuates the microcirculatory derangements evoked by experimental sepsis

Anesthesiology

Volumn 122, Issue 3, 2015, Pages 619-630

  Miranda, Marcos L ^a   Balarini, Michelle M ^b   Bouskela, Eliete ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Division of Neurosurgery   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DEXMEDETOMIDINE; LACTIC ACID; LIPOPOLYSACCHARIDE; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL GAS; ARTICLE; BLOOD FLOW VELOCITY; CAPILLARY DENSITY; CARBON DIOXIDE TENSION; CELL INTERACTION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENDOTOXEMIA; ERYTHROCYTE; FLUORESCENCE MICROSCOPY; HAMSTER MODEL; HEART RATE; LEUKOCYTE; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MALE; MEAN ARTERIAL PRESSURE; MICROANGIOPATHY; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPSIS; SKINFOLD; SYRIAN HAMSTER; TISSUE PERFUSION; ANIMAL; DRUG EFFECTS; HAMSTER; MESOCRICETUS; PATHOPHYSIOLOGY; PHYSIOLOGY;

ADRENERGIC ALPHA-2 RECEPTOR AGONISTS; ANIMALS; BLOOD FLOW VELOCITY; CRICETINAE; DEXMEDETOMIDINE; MALE; MESOCRICETUS; MICROCIRCULATION; SEPSIS;

EID: 84924286492     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/ALN.0000000000000491     Document Type: Article

References (42)

1. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR: Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29:1303-10
2. Martin GS, Mannino DM, Eaton S, Moss M: The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 2003; 348:1546-54
3. Trzeciak S, Cinel I, Phillip Dellinger R, Shapiro NI, Arnold RC, Parrillo JE, Hollenberg SM; Microcirculatory Alterations in Resuscitation and Shock (MARS) Investigators: Resuscitating the microcirculation in sepsis: The central role of nitric oxide, emerging concepts for novel therapies, and challenges for clinical trials. Acad Emerg Med 2008; 15:399-413
4. Pichot C, Ghignone M, Quintin L: Dexmedetomidine and clonidine: From second- to first-line sedative agents in the critical care setting? J Intensive Care Med 2012; 27:219-37
5. Venn RM, Hell J, Grounds RM: Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care. Crit Care 2000; 4:302-8
6. Pandharipande PP, Sanders RD, Girard TD, McGrane S, Thompson JL, Shintani AK, Herr DL, Maze M, Ely EW; MENDS Investigators: Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: An a priori-designed analysis of the MENDS randomized controlled trial. Crit Care 2010; 14:R38
7. Geloen A, Chapelier K, Cividjian A, Dantony E, Rabilloud M, May CN, Quintin L: Clonidine and dexmedetomidine increase the pressor response to norepinephrine in experimental sepsis: A pilot study. Crit Care Med 2013; 41:e431-8
8. Iida H, Iida M, Ohata H, Nagase K, Dohi S: Hypothermia attenuates the vasodilator effects of dexmedetomidine on pial vessels in rabbits in vivo. Anesth Analg 2004; 98:477-82
9. Sanders RD, Hussell T, Maze M: Sedation & immunomodulation. Anesthesiol Clin 2011; 29:687-706
10. Martins CR, Tardelli MA, Amaral JL: [Effects of dexmedetomidine on blood coagulation evaluated by thromboelastography]. Rev Bras Anestesiol 2003; 53:705-19
11. Yeh YC, Sun WZ, Ko WJ, Chan WS, Fan SZ, Tsai JC, Lin TY: Dexmedetomidine prevents alterations of intestinal microcirculation that are induced by surgical stress and pain in a novel rat model. Anesth Analg 2012; 115:46-53
12. Memiş D, Hekimoʇlu S, Vatan I, Yandim T, Yüksel M, Süt N: Effects of midazolam and dexmedetomidine on inflammatory responses and gastric intramucosal pH to sepsis, in critically ill patients. Br J Anaesth 2007; 98:550-2
13. Committee for the Update of the Guide for the Care and Use of Laboratory Animals: Guide for the Care and Use of Laboratory Animals, 8th edition. Washington, D.C., National Academies Press, 2011, pp 1-220
14. Endrich B, Asaishi K, Götz A, Messmer K: Technical report - A new chamber technique for microvascular studies in unanesthetized hamsters. Res Exp Med (Berl) 1980; 177:125-34
15. Klyscz T, Jünger M, Jung F, Zeintl H: [Cap image - A new kind of computer-assisted video image analysis system for dynamic capillary microscopy]. Biomed Tech (Berl) 1997; 42:168-75
16. Dubin A, Pozo MO, Ferrara G, Murias G, Martins E, Canullán C, Canales HS, Kanoore Edul VS, Estenssoro E, Ince C: Systemic and microcirculatory responses to progressive hemorrhage. Intensive Care Med 2009; 35:556-64
17. Taniguchi T, Kidani Y, Kanakura H, Takemoto Y, Yamamoto K: Effects of dexmedetomidine on mortality rate and inflammatory responses to endotoxin-induced shock in rats. Crit Care Med 2004; 32:1322-6
18. Taniguchi T, Kurita A, Kobayashi K, Yamamoto K, Inaba H: Dose- and time-related effects of dexmedetomidine on mortality and inflammatory responses to endotoxin-induced shock in rats. J Anesth 2008; 22:221-8
19. Qiao H, Sanders RD, Ma D, Wu X, Maze M: Sedation improves early outcome in severely septic Sprague Dawley rats. Crit Care 2009; 13:R136
20. Sharma V, McNeill JH: To scale or not to scale: The principles of dose extrapolation. Br J Pharmacol 2009; 157:907-21
21. Chuck TL, McLaughlin PJ, Arizzi-LaFrance MN, Salamone JD, Correa M: Comparison between multiple behavioral effects of peripheral ethanol administration in rats: Sedation, ataxia, and bradykinesia. Life Sci 2006; 79:154-61
22. Venn M, Newman J, Grounds M: A phase II study to evaluate the efficacy of dexmedetomidine for sedation in the medical intensive care unit. Intensive Care Med 2003; 29:201-7
23. Riker RR, Shehabi Y, Bokesch PM, Ceraso D, Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, Rocha MG; SEDCOM (Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group: Dexmedetomidine vs midazolam for sedation of critically ill patients: A randomized trial. JAMA 2009; 301:489-99
24. Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW: Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: The MENDS randomized controlled trial. JAMA 2007; 298:2644-53
25. Tan JA, Ho KM: Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: A meta-analysis. Intensive Care Med 2010; 36:926-39
26. Kirkebøen KA, Strand OA: The role of nitric oxide in sepsis - An overview. Acta Anaesthesiol Scand 1999; 43:275-88
27. Dobrucki LW, Cabrera CL, Bohr DF, Malinski T: Central hypotensive action of clonidine requires nitric oxide. Circulation 2001; 104:1884-6
28. Santos AO, Furtado ES, Villela NR, Bouskela E: Microcirculatory effects of fluid therapy and dopamine, associated or not to fluid therapy, in endotoxemic hamsters. Clin Hemorheol Microcirc 2011; 47:1-13
29. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Fertmann J, Schildberg FW, Menger MD: Microhemodynamic and cellular mechanisms of activated protein C action during endotoxemia. Crit Care Med 2004; 32:1011-7
30. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD: A chronic model for intravital microscopic study of microcirculatory disorders and leukocyte/endothelial cell interaction during normotensive endotoxemia. Shock 1999; 12:355-64
31. Uchiba M, Okajima K, Murakami K, Okabe H, Takatsuki K: Attenuation of endotoxin-induced pulmonary vascular injury by antithrombin III. Am J Physiol 1996; 270(6 Pt 1): L921-30
32. Sud R, Spengler RN, Nader ND, Ignatowski TA: Antinociception occurs with a reversal in alpha 2-adrenoceptor regulation of TNF production by peripheral monocytes/macrophages from pro- to anti-inflammatory. Eur J Pharmacol 2008; 588:217-31 33.
33. von Dossow V, Baehr N, Moshirzadeh M, von Heymann C, Braun JP, Hein OV, Sander M, Wernecke KD, Konertz W, Spies CD: Clonidine attenuated early proinflammatory response in T-cell subsets after cardiac surgery. Anesth Analg 2006; 103:809-14
34. Marik PE, Baram M: Noninvasive hemodynamic monitoring in the intensive care unit. Crit Care Clin 2007; 23:383-400
35. Koch M, De Backer D, Vincent JL, Barvais L, Hennart D, Schmartz D: Effects of propofol on human microcirculation. Br J Anaesth 2008; 101:473-8
36. Lamblin V, Favory R, Boulo M, Mathieu D: Microcirculatory alterations induced by sedation in intensive care patients. Effects of midazolam alone and in association with sufentanil. Crit Care 2006; 10:R176
37. Hoffmann JN, Vollmar B, Inthorn D, Schildberg FW, Menger MD: The thrombin antagonist hirudin fails to inhibit endotoxin-induced leukocyte/endothelial cell interaction and microvascular perfusion failure. Shock 2000; 14:528-34
38. Hoffmann JN, Vollmar B, Laschke MW, Inthorn D, Schildberg FW, Menger MD: Hydroxyethyl starch (130 kD), but not crystalloid volume support, improves microcirculation during normotensive endotoxemia. Anesthesiology 2002; 97:460-70
39. Brookes ZL, Brown NJ, Reilly CS: Intravenous anaesthesia and the rat microcirculation: The dorsal microcirculatory chamber. Br J Anaesth 2000; 85:901-3
40. Tracey KJ: Physiology and immunology of the cholinergic anti-inflammatory pathway. J Clin Invest 2007; 117:289-96
41. Martelli D, McKinley MJ, McAllen RM: The cholinergic anti-inflammatory pathway: A critical review. Auton Neurosci 2014; 182:65-9
42. Hofer S, Steppan J, Wagner T, Funke B, Lichtenstern C, Martin E, Graf BM, Bierhaus A, Weigand MA: Central sympatholytics prolong survival in experimental sepsis. Crit Care 2009; 13:R11